D-0309-2025 Class II Ongoing
Recall Details
- Product Type
- Drugs
- Report Date
- April 9, 2025
- Initiation Date
- March 11, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8160 bottles
Product Description
chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-864-01
Reason for Recall
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.
Distribution Pattern
Nationwide in the USA and PR
Code Information
Lot#s: 17232222 and 17232237, Exp 10/31/2025